GA_P advises Uriach on the minority investment in ICG and the acquisition of Laboratories Ineldea
Gómez-Acebo & Pombo has advised Grupo J. Uriach, a Catalan company specialized in the Natural Consumer Healthcare sector. Uriach, a Catalan company specialized in the Natural Consumer Healthcare sector, on the entry into its share capital of the private equity fund ICG and on the simultaneous acquisition of the French group Laboratories Ineldea.
With this acquisition, Grupo J. Uriach aims to have a turnover of 450 million euros by 2025, in addition to consolidating its leadership in the Natural Consumer Healthcare business in Europe and strengthening its position in the countries where it already operates, consolidating more powerful local businesses.
The closing of both transactions is subject, among others, to the corresponding regulatory approvals.
The GA_P team has been led by Daniel Marín, Carolina Posse and Beatriz Dosdá, partner and associates of corporate, together with Zina Safer, head of the legal department of Grupo J. Uriach. The transaction has also been advised by Iñigo Igartua, Andrea Díez de Uré and Jesús Urriza, partner and associates of competition, and Rafael Aguilera and Iñigo Arrieta, partner and associates of Banking.
Image: Daniel Marín (GA_P partner) and Zina Safer (head of the legal department of Grupo J. Uriach)
